Agios Pharmaceuticals (United States)

Agios Pharmaceuticals (United States)

Agios Pharmaceuticals Inc. is a public American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2006 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

545


Total Open
Publications

333


Total
Citations

36K


Open Access
Percentage

61%


Total
Publications

545


Total Open
Publications

333


Total
Citations

36K

Wikipedia

Website

download

Breakdown

22% 30% 9% 39%

Publisher Open

22%

Both

30%

Other Platform Open

9%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

76

Hybrid 23%

66

No Guarantees 50%

141

Other Platform Open

Domain 91%

193

Institution 16%

34

Other Internet 10%

22

Preprint 7%

15

Public 7%

15

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
194
Europe PMC
Domain
104
DOI
Other Internet
28
Figshare
Public
21
bioRxiv
Preprint
14
California Digital Library - eScholarship
Other Internet
10
University of Oxford - Oxford University Research Archive (ORA)
Institution
5
University of Michigan - Deep Blue
Institution
4
King's College London - Research Portal
Institution
4
University College London - UCL Discovery
Institution
3
1 / 5

Data updated 25 January 2024

Share

Share

Share